A switch in regulatory T cells through farm exposure during immune maturation in childhood von Schröder, P. C., Illi, S., Casaca, V. I., Lluis, A., Böck, A., Roduit, C., Depner, M., Frei, R., Genuneit, J., Pfefferle, P. I., Roponen, M., Weber, J., Braun‐Fahrländer, C., Riedler, J., Dalphin, J.C., Pekkanen, J., Lauener, R., Mutius, E., Schaub, B., Hyvärinen, Anne, Karvonen, Anne M., Hirvonen, Maija‐Riitta, Tiittanen, Pekka, Remes, Sami, Kaulek, Vincent, Dalphin, Marie‐Laure, Ege, Markus J., Loss, Georg J., Renz, Harald, Doekes, Gert, Kabesch, Michael

Volltext

Farm exposures are associated with lower percentage of circulating myeloid dendritic cell subtype 2 at age 6 von Martikainen, M.‐V., Kääriö, H., Karvonen, A., Schröder, P. C., Renz, H., Kaulek, V., Dalphin, J.‐C., Mutius, E., Schaub, B., Pekkanen, J., Hirvonen, M.‐R., Roponen, M.

Volltext

Molecular imaging as a tool to investigate heterogeneity of advanced HER2-positive breast cancer and to predict patient outcome under trastuzumab emtansine (T-DM1): the ZEPHIR tria... von Gebhart, G., Lamberts, L.E., Wimana, Z., Garcia, C., Emonts, P., Ameye, L., Stroobants, S., Huizing, M., Aftimos, P., Tol, J., Oyen, W.J.G., Vugts, D.J., Hoekstra, O.S., Schröder, C.P., Menke-van der Houven van Oordt, C.W., Guiot, T., Brouwers, A.H., Awada, A., de Vries, E.G.E., Flamen, P.

Volltext

Circulating Dendritic Cells, Farm Exposure and Asthma at Early Age von Kääriö, H., Nieminen, J. K., Karvonen, A. M., Huttunen, K., Schröder, P. C., Vaarala, O., Mutius, E., Pfefferle, P.I., Schaub, B., Pekkanen, J., Hirvonen, M.‐R., Roponen, M.

Volltext

Glycogen synthase 1 targeting reveals a metabolic vulnerability in triple-negative breast cancer von de Heer, E C, Zois, C E, Bridges, E, van der Vegt, B, Sheldon, H, Veldman, W A, Zwager, M C, van der Sluis, T, Haider, S, Morita, T, Baba, O, Schröder, C P, de Jong, S, Harris, A L, Jalving, M

Volltext

Distress, problems, referral wish, and supportive health care use in breast cancer survivors beyond the first year after chemotherapy completion von Admiraal, J. M., Hoekstra-Weebers, J. E. H. M., Schröder, C. P., Tuinier, W., Hospers, G. A. P., Reyners, Anna K. L.

Volltext

Axillary staging for breast cancer during pregnancy: feasibility and safety of sentinel lymph node biopsy von Han, S. N., Amant, F., Cardonick, E. H., Loibl, S., Peccatori, F. A., Gheysens, O., Sangalli, C. A., Nekljudova, V., Steffensen, K. Dahl, Mhallem Gziri, M., Schröder, C. P., Lok, C. A. R., Verest, A., Neven, P., Smeets, A., Pruneri, G., Cremonesi, M., Gentilini, O.

Volltext

Correction: Glycogen synthase 1 targeting reveals a metabolic vulnerability in triple-negative breast cancer von de Heer, E. C, Zois, C. E, Bridges, E, van der Vegt, B, Sheldon, H, Veldman, W. A, Zwager, M. C, van der Sluis, T, Haider, S, Morita, T, Baba, O, Schröder, C. P, de Jong, S, Harris, A. L, Jalving, M

Volltext

Zirconium-89 (89Zr)-labeled bispecific T-cell engager (BiTE®) AMG 211 PET imaging to determine AMG 211 biodistribution in patients with gastrointestinal (GI) adenocarcinomas von Moek, K L, Waaijer, S J H, Kok, I C, Suurs, F V, Brouwers, A, Menke-van der Houven van Oordt, C W, Wind, T T, Gietema, J A, Schroder, C P, Mahesh, S V K, Jorritsma-Smit, A, Lub-De Hooge, M N, Fehrmann, R S N, de Groot, D J, de Vries, E G E

Volltext

High-dose chemotherapy (HDCT) with hematopoietic stem cell transplantation (HSCT) in high-risk breast cancer (BC) patients with ≥4 involved axillary lymph nodes (ALN): 20-year foll... von Steenbruggen, T.G., Steggink, L.C., Seynaeve, C.M., van der Hoeven, J.J.M., Hooning, M.J., Jager, A., Konings, I.R., Kroep, J.R., Smit, W.M., Tjan-Heijnen, V.C.G., van der Wall, E., Bins, A.D., Linn, S.C., Schaapveld, M., van Leeuwen, F.E., Schroder, C.P., van Tinteren, H., de Vries, E.G.E., Sonke, G.S., Gietema, J.A.

Volltext

Targeting breast cancer through its microenvironment: current status of preclinical and clinical research in finding relevant targets von Nienhuis, H H, Gaykema, S B M, Timmer-Bosscha, H, Jalving, M, Brouwers, A H, Lub-de Hooge, M N, van der Vegt, B, Overmoyer, B, de Vries, E G E, Schröder, C P

Volltext

Molecular imaging of breast cancer von Munnink, T.H. Oude, Nagengast, W.B, Brouwers, A.H, Schröder, C.P, Hospers, G.A, Hooge, M.N. Lub-de, van der Wall, E, van Diest, P.J, de Vries, E.G.E

Volltext

Impact of primary local treatment on the development of distant metastases or death through locoregional recurrence in young breast cancer patients von Bantema-Joppe, E. J., van den Heuvel, E. R., de Munck, L., de Bock, G. H., Smit, W. G. J. M., Timmer, P. R., Dolsma, W. V., Jansen, L., Schröder, C. P., Siesling, S., Langendijk, J. A., Maduro, J. H.

Volltext

Performance of BRCA1/2 mutation prediction models in male breast cancer patients von Moghadasi, S., Grundeken, V., Janssen, L.A.M., Dijkstra, N.H., Rodríguez‐Girondo, M., van Zelst‐Stams, W.A.G., Oosterwijk, J.C., Ausems, M.G.E.M., Oldenburg, R.A., Adank, M.A., Blom, E.W., Ruijs, M.W.G., van Os, T.A.M., van Deurzen, C.H.M., Martens, J.W.M., Schroder, C.P., Wijnen, J.T., Vreeswijk, M.P.G., van Asperen, C.J.

Volltext

Enhanced pulmonary uptake on 18F-FES-PET/CT scans after irradiation of the thoracic area: related to fibrosis? von Venema, C. M., de Vries, E. F. J., van der Veen, S. J., Dorrius, M. D., van Kruchten, M., Schröder, C. P., Hospers, G. A. P., Glaudemans, A. W. J. M.

Volltext

An in vitro model for purging of tumour cells from ovarian tissue von Schröder, C.P., Timmer‐Bosscha, H., Wijchman, J.G., de Leij, L.F.M.H., Hollema, H., Heineman, M.J., de Vries, E.G.E.

Volltext

Severe disabling tendinopathy caused by anastrazole von Martens, H. A., Schröder, C. P., van der Eerden, P. J. M., Willemse, P. H. B., Posthumus, M. D.

Volltext

Telomere length in breast cancer patients before and after chemotherapy with or without stem cell transplantation von Schröder, C P, Wisman, G B A, Jong, S de, Graaf, W T A van der, Ruiters, M H J, Mulder, N H, Leij, L F M H de, Zee, A G J van der, Vries, E G E de

Volltext

Evaluation of FES (16α-[18F]-fluoro-17β-estradiol) PET for (re)staging of patients with clinical (locally) advanced or locoregional recurrent estrogen receptor positive breast canc... von Iqbal, R., Mo, C., Cysouw, M.C.F., Glaudemans, A.W.J.M., Hospers, G.A.P., Schroder, C.P., Venema, C.C.M., Menke-van der Houven van Oordt, C.W.

Volltext

89Zr-trastuzumab PET supports clinical decision making in breast cancer patients, when HER2 status cannot be determined by standard work up von Bensch, Frederike, Brouwers, A. H., Lub-de Hooge, M. N., de Jong, J. R., van der Vegt, B., Sleijfer, S., de Vries, E. G. E., Schröder, C. P.

Volltext